Ogilvy announced today that Adam Hessel has been appointed Chief Creative Officer of Ogilvy Health. In this role he will oversee all creative output for Ogilvy Health in North America and serve on Ogilvy Health’s executive leadership team. He will also join Ogilvy’s Worldwide Creative Council.
In the COVID age, new health policies have brought pharma further into the spotlight, causing major changes across the industry. These changes are posing profound challenges for healthcare marketers in 2022, but also tremendous opportunities. I see several major changes that will transform to a great extent how agencies and the healthcare industry market to healthcare providers and their patients.
The jury weighing fraud charges against former Theranos CEO Elizabeth Holmes will start their second week of deliberations Monday. Holmes faces 11 criminal charges alleging that she duped investors and patients by hailing her company’s blood-testing technology as a medical breakthrough when in fact it was prone to wild errors.
Demonstrating ROI (return on investment) is crucial for medical marketers to show their value to stakeholders, and digital marketing has led today’s decision-makers to expect immediate data to help them stay competitive. Meanwhile, it’s often challenging to show which part of any marketing campaign directly increases a business’s bottom line. And in healthcare, HIPAA privacy barriers create an additional challenge to utilizing digital marketing.
With flu season bearing down and the pandemic still in full swing, CVS is rolling out new ways to encourage customers to get their flu shots using artificial intelligence (AI). The pharmacy chain has teamed up with IBM Watson Advertising to create a campaign of personalized mobile messaging that attempts to identify and target at-risk areas before the flu hits.